Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.96 USD
Change Today +0.17 / 6.09%
Volume 1.1M
IDRA On Other Exchanges
As of 8:10 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Sudhir Agrawal D.Phil., F.R.S.C.

President of Research and Director,Idera Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Sudhir Agrawal, D.Phil. F.R.S.C, has been the President of Research at Idera Pharmaceuticals, Inc. since December 1, 2014. Dr. Agrawal served as the Chief Executive Officer of Idera Pharmaceuticals, Inc. since August 30, 2004 until December 1, 2014 and its President since September 16, 2008 until December 1, 2014. Dr. Agrawal joined Idera Pharmaceuticals, Inc. in 1990 and served as its Chief Scientific Officer since January 1993 and Senior Vice President of Discovery ...

Read Full Background

Corporate Headquarters*

167 Sidney Street
Cambridge, Massachusetts 02139

United States

Phone: 617-679-5500
Fax: 617-679-5592

Board Members Memberships*

President of Research and Director


MS 1975
Allahabad University
PhD 1980
Allahabad University
BS 1973
Allahabad University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$856,440

Stock Options*

All Other Compensation$32,681
Exercisable Options3,443,426
Exercisable Options Value$6,451,750
Unexercisable Options903,125
Unexercisable Options Value$472,281
Total Value of Options$6,924,030
Total Number of Options4,346,551

Total Compensation*

Total Annual Cash Compensation$889,121
Total Short Term Compensation$856,440
Other Long Term Compensation$32,681
Total Calculated Compensation$3,042,596
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IDRA:US $2.96 USD +0.17


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IDERA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at